<DOC>
	<DOC>NCT00060918</DOC>
	<brief_summary>To evaluate the effects of two different antihypertensive medications in the drug class of beta-blockers on control of glucose in Type II diabetic patients with high blood pressure.</brief_summary>
	<brief_title>Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Inclusion criteria: Patients at screening must be insulin producing Type II diabetics (C peptide positive). Must have a history of mild to moderate hypertension (140179 systolic; 9019 diastolic). Must be on stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments. Patient''s laboratory result for HbA1c must be 6.5 8.5 (drug treated) or 6.5 7.5 (diet alone). Must be on a stable antidiabetic regimen (drug treated or diet alone). Exclusion criteria: Patients using betablocker therapy.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>hypertension</keyword>
	<keyword>beta-blockers</keyword>
</DOC>